Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy

Saved in:
Bibliographic Details
Published inBlood Vol. 90; no. 3; pp. 1014 - 1021
Main Authors MANDELLI, F, DIVERIO, D, LEONI, F, LISO, V, PETTI, M. C, RODEGHIERO, F, SAGLIO, G, VEGNA, M. L, VISANI, G, JEHN, U, WILLEMZE, R, MUUS, P, AVVISATI, G, PELICCI, P. G, BIONDI, A, LO COCO, F, LUCIANO, A, BARBUI, T, BERNASCONI, C, BROCCIA, G, CERRI, R, FALDA, M, FIORITONI, G
Format Journal Article
LanguageEnglish
Published Washington, DC The Americain Society of Hematology 01.08.1997
Subjects
Antineoplastic agents
Biological and medical sciences
Chemotherapy
Medical sciences
Pharmacology. Drug treatments
Antineoplastic agent
Human
Promyelocytic leukemia
Drug combination
Acute
Malignant hemopathy
Retinoids
Antibiotic
Chemotherapy
Treatment
Alpha-Peptide chain
Remission
Anthracyclins
Idarubicin
Retinoic acid
Hybrid gene
Biological receptor
Tretinoin
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020